Media Contacts:
Kristy Marks
kristy.marks@bausch.com
(908) 927-0683
BAUSCH + LOMB TO PRESENT NEW SCIENTIFIC DATA DURING THE AMERICAN ACADEMY OF OPTOMETRY MEETING IN SAN ANTONIO
Bausch + Lomb Will Also Showcase its Current Portfolio of Pharmaceutical, Consumer Healthcare and Vision Care Products in Booth #1843 and Present Educational Events
BRIDGEWATER, N.J., Nov. 6, 2018 – Bausch + Lomb, a leading global eye health company, today announced the presentation of five posters during the American Academy of Optometry (AAO) meeting in San Antonio (Nov. 7-10, 2018). These presentations will feature an integrated analysis from two Phase 3 studies evaluating Bausch + Lomb’s investigational product, submicron loteprednol etabonate ophthalmic gel, 0.38%, as well as new data on LUMIFY™ redness reliever eye drops, Bausch + Lomb ULTRA® contact lenses and two analyses from the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) study, which is the only ongoing multicenter survey of antibiotic resistance patterns specific to ocular pathogens in the United States. The company will also offer a variety of educational programs and feature its current portfolio of Pharmaceuticals, Consumer Healthcare and Vision Care products in its booth (#1843).
“Bausch + Lomb is committed to conducting research that supports the development of our pipeline products and further demonstrates the clinical benefits of our current portfolio of products, like LUMIFY and Bausch + Lomb ULTRA,” said Joe Gordon, U.S. President, Bausch + Lomb. “We look forward to the opportunity to connect with eye care professionals at the AAO meeting to present these new data, discuss industry trends, feature our latest products and host a number of educational programs that are designed to help meet the needs of our customers and, ultimately, their patients.”
Scientific Poster Presentations
The full schedule of research to be presented includes:
- “Lack of Tachyphylaxis with Low Dose Brimonidine for Relief of Ocular Redness.” Karpecki, Paul M.; Hosten, Lester O. Poster #23, available on Thursday, Nov. 8.
- “Integrated Analysis of Two Phase 3 Trials Evaluating Submicron Loteprednol Etabonate 0.38% for the Treatment of Inflammation and Pain Post-Cataract Surgery.” Cavet, Megan; Williams, Jon; Vittitow, Jason. Poster #25, available on Thursday, Nov. 8.
- “Patient Comfort, Vision and Cleanliness over 12-Months of Samfilcon A Lens Wear.” Reindel, William; Steffen, Robert; Mosehauer, Gary. Poster #150, available on Friday, Nov. 9.
- “Antibiotic Resistance among Ocular Pathogens – Latest Results from the ARMOR Surveillance Study.” Sanfilippo, Christine M.; Asbell, Penny A.; DeCory, Heleen H. Poster #38, available on Thursday, Nov. 8.
- “Antibiotic Resistance Among Conjunctival-Sourced Ocular Pathogens Collected in the ARMOR Surveillance Study.” Sanfilippo, Christine M.; Asbell, Penny A.; DeCory, Heleen H. Poster #69, available on Friday, Nov. 9.
Pharmaceutical, Consumer Healthcare and Vision Care Products In Booth
During the meeting in the company’s booth, Bausch + Lomb will feature the company’s broad portfolio of Pharmaceuticals, Consumer Healthcare and Vision Care products, including Biotrue® ONEday for Astigmatism contact lenses. In August, the company announced the expansion of parameters for Biotrue ONEday for Astigmatism from +4.00D to -9.00D, in three cylinder powers of -0.75, -1.25 and -1.75, and additional parameters in a -2.25 cylinder.
Similar to the other products in the Biotrue ONEday brand family, Biotrue ONEday for Astigmatism starts and ends the day with more moisture than other leading daily disposables. It has a patented dehydration barrier, that allows the lens to maintain nearly 100 percent of its moisture for a full 16 hours.1 In addition, Biotrue ONEday for Astigmatism contact lenses offer an evolved peri-ballast design, featuring a tapered edge to limit lid interaction, and spherical aberration control to help reduce halos and glare, particularly in low light conditions.
Featured Educational Programs
AAO attendees are also invited to attend a series of educational programs led by a distinguished group of speakers. The courses will focus on a variety of topics including red eye, ocular nutrition, and scleral lenses. The full schedule includes:
Wednesday, Nov. 7
AAO attendees are invited to attend “Did You See That?” with Drs. Art Epstein, Ben Gaddie, and Paul Karpecki who will lead a clinical discussion of challenging patient cases featuring products from Bausch + Lomb’s Vision Care and Pharmaceutical portfolio. The session will be held from 11:50 a.m. – 12:45 p.m. at the Henry B. Gonzalez Convention Center (900 E. Market St., San Antonio, TX 78205) in Classroom 160: Room 007AB, River Level.
Thursday, Nov. 8
Jeffry Gerson, O.D. will present the “Making Sense of Ocular Nutrition,” Vision Theater Lecture session, which will focus on advancements in eye vitamins and supplements. The session will be held from 11:30 a.m. – 12:15 p.m. at the Henry B. Gonzalez Center (900 E. Market St., San Antonio, TX 78205) in the Exhibit Hall Floor, Vision Theater East.
Attendees are invited to attend the “Ocular Surface Disease” Vision Theater Lecture session hosted by Jason Jedlicka, O.D., FAAO, FSLS. The session will be held from 12:40 – 1:20 p.m. at Henry B. Gonzalez Center (900 E. Market St., San Antonio, TX 78205) in Vision Theater West.
“Troubleshooting,” a Vision Theater Lecture session hosted by Shelly Cutler, O.D., FAAO, on successful methods for fitting scleral lenses, will be held from 1:25 – 1:55 p.m., at the Henry B. Gonzalez Center (900 E. Market St., San Antonio, TX 78205) in Vision Theater West.
Friday, Nov. 9
Jeffry Gerson, O.D., will present an encore session of the “Making Sense of Ocular Nutrition,” Vision Theater lecture program. This session will be held from 12:30 – 1:20 p.m. at the Henry B. Gonzalez Center (900 E. Market St., San Antonio, TX 78205) in the Exhibit Hall Floor, Vision Theater West.
About Bausch + Lomb
Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies Inc., is a leading global eye health organization that is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.
References
1.Data on file. Bausch & Lomb Incorporated. Rochester, NY.
###
®/™ are trademarks of Bausch & Lomb Incorporated or its affiliates. Any other product/brand names are trademarks of the respective owners.
© 2018 Bausch & Lomb Incorporated. MTB.0534.USA.18
United States
